Articles dans des revues avec comité de lecture (260)
  1. 214. Snell, B. J., Short, J. L., Drago, J., Ledent, C., & Lawrence, A. J. (2000). Characterisation of central adenosine A(1) receptors and adenosine transporters in mice lacking the adenosine A(2a) receptor. Brain research, 877(2), 160-169.
  2. 215. Hájos, N., Katona, I., Naiem, S. S., Mackie, K., Ledent, C., Mody, I., & Freund, T. F. (2000). Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. European journal of neuroscience, 12(9), 3239-3249. doi:10.1046/j.1460-9568.2000.00217.x
  3. 216. Snell, B. J., Short, J. L., Drago, J., Ledent, C., & Lawrence, A. J. (2000). Visualisation of AMPA binding sites in the brain of mice lacking the adenosine A(2a) receptor. Neuroscience letters, 291(2), 97-100.
  4. 217. El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J., & Vaugeois, J.-M. (2000). SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptor. European journal of pharmacology, 401(1), 63-77.
  5. 218. Obinu, M. C., Imperato, A., Böhme, G. A., Ledent, C., Parmentier, M., Fattore, L., Cossu, G., Mascia, M. S., & Fratta, W. (2000). Role of cannabinoid CB1 receptor in morphine rewarding effects in mice. Pharmacy and pharmacology communications, 6(6), 281-285.
  6. 219. Michils, A., Baldassarre, S., Ledent, C., Mairesse, M., Gossart, B., & Duchateau, J. (2000). Early effect of ultrarush venom immunotherapy on the IgG antibody response. Allergy, 55(5), 455-462. doi:10.1034/j.1398-9995.2000.00412.x
  7. 220. El Yacoubi, M., Ledent, C., Ménard, J. F., Parmentier, M., Costentin, J., & Vaugeois, J.-M. (2000). The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. British Journal of Pharmacology, 129(7), 1465-1473. doi:10.1038/sj.bjp.0703170
  8. 221. Svenningsson, P., Lindskog, M., Ledent, C., Parmentier, M., Greengard, P., Fredholm, B. B., & Fisone, G. (2000). Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proceedings of the National Academy of Sciences of the United States of America, 97(4), 1856-1860.
  9. 222. El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J., & Vaugeois, J.-M. (2000). The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists. Psychopharmacologia, 148(2), 153-163.
  10. 223. Valverde, O., Ledent, C., Beslot, F., Parmentier, M., & Roques, B. P. (2000). Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors. European journal of neuroscience, 12(2), 533-539. doi:10.1046/j.1460-9568.2000.00929.x
  11. 224. Svenningsson, P., Lindskog, M., Ledent, C., Parmentier, M., Greengard, P., Fredholm, B. B., & Fisone, G. (2000). Regulation of the phosphorylation of the dopamine-and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proceedings of the National Academy of Sciences of the United States of America, 97(4), 1856-1860.
  12. 225. Böhme, G. A., Laville, M., Ledent, C., Parmentier, M., & Imperato, A. (2000). Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience, 95(1), 5-7.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>